Gilead Sciences’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.9M Hold
4,854,443
1.94% 5
2025
Q1
$6.65M Hold
4,854,443
0.56% 7
2024
Q4
$15M Buy
+4,854,443
New +$15M 0.97% 8